# Efficacy of Nano-PSO in Parkinson's Disease.

> **NCT05142085** · NA · UNKNOWN · sponsor: **Distribuidora Biolife SA de CV** · enrollment: 170 (estimated)

## Conditions studied

- Parkinson Disease

## Interventions

- **DIETARY_SUPPLEMENT:** nano-PSO
- **OTHER:** placebo

## Key facts

- **NCT ID:** NCT05142085
- **Lead sponsor:** Distribuidora Biolife SA de CV
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2021-09-20
- **Primary completion:** 2023-01-03
- **Final completion:** 2023-06-30
- **Target enrollment:** 170 (ESTIMATED)
- **Last updated:** 2021-12-02


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05142085

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05142085, "Efficacy of Nano-PSO in Parkinson's Disease.". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT05142085. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*